Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World

The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in three months from India. We update our systematic review on COVID-19-associated mucormycosis (CAM) till June 21st, 2021, comparing cases report...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthu, Valliappan, Rudramurthy, Shivaprakash M., Chakrabarti, Arunaloke, Agarwal, Ritesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375614/
https://www.ncbi.nlm.nih.gov/pubmed/34414555
http://dx.doi.org/10.1007/s11046-021-00584-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375614/
https://www.ncbi.nlm.nih.gov/pubmed/34414555
http://dx.doi.org/10.1007/s11046-021-00584-8

Ejemplares similares